Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023

BUY
$29.32 - $35.99 $16,829 - $20,658
574 Added 29.71%
2,506 $80,000
Q1 2023

Apr 13, 2023

SELL
$30.15 - $48.79 $5,396 - $8,733
-179 Reduced 8.48%
1,932 $59,000
Q4 2022

Jan 23, 2023

SELL
$36.73 - $51.6 $1,726 - $2,425
-47 Reduced 2.18%
2,111 $0
Q3 2022

Oct 26, 2022

BUY
$39.79 - $70.31 $30,518 - $53,927
767 Added 55.14%
2,158 $102,000
Q2 2022

Jul 25, 2022

SELL
$29.86 - $62.36 $294,598 - $615,243
-9,866 Reduced 87.64%
1,391 $53,000
Q1 2022

May 02, 2022

BUY
$53.73 - $82.16 $13,539 - $20,704
252 Added 2.29%
11,257 $645,000
Q4 2021

Jan 28, 2022

BUY
$68.02 - $99.06 $748,560 - $1.09 Million
11,005 New
11,005 $876,000

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.65B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.